Invacare (IVC) Stock Price, News & Analysis

Company Overview

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.35 to $0.74
• 52-Week Range: N/A
• Volume: 33,301 shs
• Average Volume: 240,305 shs
• Market Capitalization: $20.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVC Stock Analysis - Frequently Asked Questions

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invacare investors own include Pfizer (PFE), Intel (INTC), Exxon Mobil (XOM), Micron Technology (MU), Occidental Petroleum (OXY), Devon Energy (DVN) and Global Blood Therapeutics (GBT).

Company Calendar

• Last Earnings: 10/27/2021
• Today: 1/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:IVC
• CUSIP: 46120310
• CIK: 742112
• Web: www.invacare.com
• Phone: (440) 329-6000
• Fax: 877-619-7996
• Employees: 3,000
• Year Founded: 1885

Profitability

• EPS (Most Recent Fiscal Year): ($2.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-45,560,000.00
• Net Margins: -9.99%
• Pretax Margin: -9.38%
• Return on Equity: -37.76%
• Return on Assets: -7.18%

Debt

• Debt-to-Equity Ratio: 4.82
• Current Ratio: 1.32
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $872.46 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.77
• Book Value: $5.54 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 37,760,000
• Free Float: 35,153,000
• Market Cap: $20.01 million
• Optionable: Optionable
• Beta: 0.38